<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01174992</url>
  </required_header>
  <id_info>
    <org_study_id>400-09-001</org_study_id>
    <secondary_id>2009-016501-41</secondary_id>
    <nct_id>NCT01174992</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair</brief_title>
  <official_title>A Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>OMRIX Biopharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ethicon, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the safety and efficacy of EVICEL for use as an
      adjunct to dura sutures in elective cranial surgery to provide intraoperative watertight
      closure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, multi-center controlled study evaluating the effectiveness of EVICEL*
      as an adjunct to sutured dural closure compared to control to obtain an intraoperative
      watertight dural closure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of success</measure>
    <time_frame>Day 1 (intraoperative)</time_frame>
    <description>Proportion of success (intraoperative watertight closure) in the treatment of intraoperative CSF leakage.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of CSF leakage</measure>
    <time_frame>Day 5 post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of CSF leakage</measure>
    <time_frame>Day 30 post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>up to 30 days post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of surgical site infections</measure>
    <time_frame>Day 5 and 30 post-op</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">139</enrollment>
  <condition>Dura Defects</condition>
  <arm_group>
    <arm_group_label>Evicel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sutures only</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Evicel</intervention_name>
    <description>EVICEL is a human plasma derived fibrin sealant</description>
    <arm_group_label>Evicel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sutures only</intervention_name>
    <description>Standard of care</description>
    <arm_group_label>Sutures only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient undergoing elective craniotomy/craniectomy

          -  Age greater than or equal to 18 years

          -  Patients who are able and willing to comply with the procedures required by the
             protocol.

          -  Signed and dated written informed consent from the subject or from his/her legal
             representative prior to any study-related procedures.

        Exclusion Criteria:

          -  Chemotherapy or radiation therapy within 7 days following surgery.

          -  Conditions compromising the immune system.

          -  Known hypersensitivity to the components (human fibrinogen, arginine hydrochloride,
             glycine, sodium chloride, sodium citrate, calcium chloride, human thrombin, human
             albumin, mannitol and sodium acetate) of the investigational product.

          -  Female subjects of childbearing potential with a positive pregnancy test prior to
             surgery.

          -  Female subjects who are breastfeeding or intend to become pregnant during the clinical
             study period.

          -  Participation in another clinical trial with exposure to another investigational drug
             or device within 30 days prior to enrollment.

          -  Major intraoperative findings or complications identified by the surgeon that may
             preclude conduct of the planned surgical procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Hart, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ethicon, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurosurgery, Ziekenhuis Oost Limburg</name>
      <address>
        <city>Genk</city>
        <zip>B-3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, University Hospital of Liège</name>
      <address>
        <city>Liège</city>
        <zip>B-4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurosciences and Rehabilitation, Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>FI-33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurochirurgie B, Hopital Neurologique de Lyon</name>
      <address>
        <city>Cedex</city>
        <zip>696 BRON</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie, Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <zip>D-45122</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, University Giessen-Marburg</name>
      <address>
        <city>Giessen</city>
        <zip>35385</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, Klinikum Ingolstadt GmbH</name>
      <address>
        <city>Ingolstadt</city>
        <zip>85049</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery University Clinics of Schleswig-Holstein Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>D-24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU Medical Centre</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, John Radcliffe Hospital</name>
      <address>
        <city>Headington</city>
        <state>Oxford</state>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, Ninewells Hospital &amp; Medical School</name>
      <address>
        <city>Dundee</city>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Edinburgh Centre for Neuro-Oncology, Western General Hospital</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH4 2XU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2010</study_first_submitted>
  <study_first_submitted_qc>August 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2010</study_first_posted>
  <last_update_submitted>June 19, 2012</last_update_submitted>
  <last_update_submitted_qc>June 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fibrin sealant</keyword>
  <keyword>CSF leak</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

